Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03579901 · ClinicalTrials.gov registry record · NA
Study of the Safety and Effectiveness of Motiva Implants®
A NA study of Breast Implants, sponsored by Motiva USA.
- Active
- Registry status
- NA
- Development phase
- 800
- Enrollment target
- 20
- Study locations
NCT03579901 is a NA study of Breast Implants that is active but no longer recruiting, run by Motiva USA. The registered enrollment target is 800 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT03579901, a NA study of Breast Implants, is active but no longer recruiting, sponsored by Motiva USA.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 800 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.
Conditions Studied
Interventions
- DEVICE Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants
Study Locations (20)
New York
- Mark D. Epstein, MD, FACS/ Center for Aesthetic Surgery - Hauppauge
- NYU Plastic Surgery Associates - New York
- May Center for Mount Sinai Doctors - New York
- Fifth Avenue Millennium Aesthetic Surgery, PLLC - New York
California
- Gerald Minitti, MD, FACS - Beverly Hills
- Steven Teitelbaum, MD, FACS - Santa Monica
- Westlake Cosmetic Surgery Center - Westlake Village
Illinois
- Northwestern Plastic Surgery - Chicago
- Northwestern Specialists in Plastic Surgery, S.C. - Chicago
Oregon
- Movassaghi Plastic Surgery & Ziba Medical Spa - Eugene
- Portland Plastic Surgery - Portland
Colorado
- The Center for Cosmetic Surgery - Golden
Georgia
- Emory University Hospital - Atlanta
Indiana
- Meridian Plastic Surgery Center - Indianapolis
Kentucky
- CaloAesthetics® Plastic Surgery Center - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2018-04-06 |
| Est. Completion | 2033-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03579901
The ClinicalTrials.gov registry entry for NCT03579901 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Motiva USA, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Implants appearing as the primary indexed condition, and to 1 intervention - of which Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants is the first listed.
NCT03579901 reports 20 study locations spanning 13 distinct geographic areas - top geographies include New York, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT03579901 about?
NCT03579901 is a clinical study titled "Study of the Safety and Effectiveness of Motiva Implants®". This study evaluates the safety and effectiveness Motiva Implants® in women who are undergoing primary breast augmentation, primary breast reconstruction or revision breast surgery.
What is the current status of trial NCT03579901?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 800 participants. The study started on 2018-04-06. Estimated completion is 2033-02-28.
What conditions does trial NCT03579901 study?
This clinical trial studies the following conditions: Breast Implants.
What interventions are being tested in trial NCT03579901?
The interventions under investigation include: Silicone gel-filled breast implants - Motiva Implants® Investigational breast implants (DEVICE).
Who is sponsoring clinical trial NCT03579901?
This trial is sponsored by Motiva USA, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03579901 being conducted?
This trial has 20 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.